Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-18FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for Viibryd (vilazodone hydrochloride).
-
FDA approval · 2023-08-18FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for paroxetine submitted by Padagis US LLC. This action represents an additional regulatory appr…
-
FDA approval · 2023-08-18FDA Approved: TRINTELLIX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for TRINTELLIX (vortioxetine) submitted by Takeda Pharmaceuticals America, Inc., to update or expand…
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Venlafaxine Hydrochloride from Dr. Reddy's Laboratories Limited for a generic venlafaxine hydroc…
-
FDA approval · 2023-08-18FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine hydrochloride from Alembic Pharmaceuticals Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-18FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for citalopram hydrobromide from Aurobindo Pharma Limited, representing a generic version approval.
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
FDA approval · 2023-08-16FDA Approved: DOXEPIN — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a generic doxepin product (DOXEPIN) from Zydus Lifesciences Limited.
-
FDA approval · 2023-08-16FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved the original application for a generic doxepin hydrochloride product from Amneal Pharmaceuticals NY LLC. The generic is ind…
-
FDA approval · 2023-08-15FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd)
The FDA approved a generic formulation of nortriptyline hydrochloride from Advagen Pharma Ltd under an Original Application.
-
FDA approval · 2023-08-10FDA Approved: FLUOXETINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine from Torrent Pharmaceuticals Limited, enabling the generic antidepressant to be manuf…
-
FDA approval · 2023-08-09FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., indicating an update to the produ…
-
FDA approval · 2023-08-08FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application to market a generic form of bupropion hydrochloride, indi…
-
FDA approval · 2023-08-02FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental ANDA for a generic formulation of bupropion hydrochloride by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2023-07-28FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Dr. Reddys Laboratories Inc.)
FDA approved a supplemental application for Dr. Reddy's Laboratories' generic Bupropion Hydrochloride SR, expanding its regulatory approval …
-
FDA approval · 2023-07-18FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental ANDA from Alembic Pharmaceuticals Limited for vilazodone hydrochloride, granting approval of a generic version o…
-
FDA approval · 2023-07-17FDA Approved: ARIPIPRAZOLE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for aripiprazole from Ascend Laboratories, allowing a generic version to be marketed.
-
FDA approval · 2023-07-07FDA Approved: VILAZODONE HYDROCHLORIDE — Original Application (Northstar Rx LLC)
FDA approved the original application for Vilazodone hydrochloride from Northstar Rx LLC, enabling a generic version of the antidepressant i…
-
FDA approval · 2023-06-28FDA Approved: MIRTAZAPINE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Mirtazapine by Prasco Laboratories, enabling a generic version of the antidepressant to be marke…
-
FDA approval · 2023-06-27FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved the original abbreviated new drug application for doxepin hydrochloride from Micro Labs Limited. Doxepin hydrochloride is used …
-
FDA approval · 2023-06-15FDA Approved: ARIPIPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for aripiprazole from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2023-06-12FDA Approved: ARIPIPRAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for ARIPIPRAZOLE submitted by Unichem Pharmaceuticals (USA), Inc., enabling the generic product to b…
-
FDA approval · 2023-06-07FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride by Macleods Pharmaceuticals Limited.
-
FDA approval · 2023-06-07FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for vilazodone hydrochloride from Accord Healthcare Inc., authorizing a generic version of the antid…
-
FDA approval · 2023-06-07FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Quetiapine Fumarate by Macleods Pharmaceuticals Limited under ANDA203359.